Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anti-inflammatory agent 52 (compound 7j) is an orally active, selective COX-2 inhibitor that induces G2/M phase arrest and exhibits anti-HT29 transfer activity. It demonstrates moderate anti-inflammatory efficacy and a notable safety profile, and uniquely inhibits tumor growth in mouse models, indicative of its anticancer properties [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Anti-inflammatory agent 52 (compound 7j) is an orally active, selective COX-2 inhibitor that induces G2/M phase arrest and exhibits anti-HT29 transfer activity. It demonstrates moderate anti-inflammatory efficacy and a notable safety profile, and uniquely inhibits tumor growth in mouse models, indicative of its anticancer properties [1]. |
In vitro | Anti-inflammatory agent 52 (compound 7j) at 0.25 μM for 24 hours inhibits colony formation in HT29 cells and induces G2/M phase cell cycle arrest [1]. |
In vivo | Anti-inflammatory agent 52, also known as compound 7j, at a dosage of 50 mg/kg administered orally every other day for two weeks, was found to reduce tumor volume and weight in mice with Ehrlich solid carcinoma [1]. |
Molecular Weight | 452.95 |
Formula | C24H21ClN2O3S |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.